Gerresheimer AG
ISIN: DE000A0LD6E6
WKN: A0LD6E
11 December 2024 08:00AM

EQS-News: Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group

Gerresheimer AG · ISIN: DE000A0LD6E6 · EQS - Company News
Country: Germany · Primary market: Germany · EQS NID: 2048177

EQS-News: Gerresheimer AG / Key word(s): Mergers & Acquisitions
Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group

11.12.2024 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group

  • Complementary product portfolio and broad footprint of production sites in Europe
  • Strengthening the market position as a full-service provider for the pharma and biotech industry
  • Strategic reset of Moulded Glass business

Düsseldorf, December 11, 2024 - Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has successfully completed the acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group announced in May 2024. The closing was preceded by the fulfillment of customary closing conditions. Bormioli Pharma has a portfolio of pharmaceutical primary packaging made of glass and plastic as well as closure solutions, accessories and dosing systems that is complementary to Gerresheimer. With this acquisition, Gerresheimer strengthens its European footprint with additional production sites and underpins its market position as a leading full-service provider and global partner for the pharma and biotech industries. Gerresheimer expects the acquisition to be accretive to the Group's Adj. EBITDA margin and Adj. EPS from the first year onwards through synergies. On February 26, 2025, Gerresheimer will publish a new guidance for the combined company together with the results for the financial year 2024.

"Following the successful completion of the acquisition, we can now focus on the integration of Bormioli Pharma into the Gerresheimer Group," explains Dietmar Siemssen, CEO of Gerresheimer AG. "We are convinced that our customers will benefit from the expansion of the product portfolio and new, integrated systems and solutions."

Complementary, attractive product portfolio

In 2023, Bormioli Pharma generated sales of around EUR 371 million and an Adj. EBITDA margin of around 22%. The company manufactures pharmaceutical primary packaging made of glass and plastic as well as closure solutions, accessories and dosing systems. In the plastics segment, Bormioli Pharma is one of the leading suppliers of pharmaceutical plastic systems and solutions. In the glass segment, Bormioli Pharma has an attractive portfolio for parenteral and other pharmaceutical primary packaging.

Strategic reset of Moulded Glass business

The acquisition creates a new, strong Moulded Glass unit with a diversified product portfolio for the pharmaceutical, cosmetics, food and beverage industries. This globally active unit offers new options for a strategic reset for the best growth prospects and competitiveness, which will be evaluated in the coming months.

New guidance for combined company in February 2025

Bormioli Pharma will become part of the Gerresheimer Group and will be fully consolidated retroactively as of December 1, 2024, the start of Gerresheimer's new financial year 2025. Therefore, on February 26, 2025, together with the results for the financial year 2024, Gerresheimer will publish a new guidance for 2025 and a new mid-term guidance for the combined company.     

 

About Bormioli Pharma

Established in 1825, Bormioli Pharma is a leading pharma primary packaging manufacturer serving the industry with complete solutions, including glass and plastic bottles, plastic and aluminum closures and accessories. Bormioli Pharma's products are designed and manufactured to drive innovation and deliver effective solutions to the growing challenges of sustainability. Bormioli Pharma has become part of the Gerresheimer Group in December 2024, an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. Gerresheimer operates over 40 production sites in 16 countries in Europe, America and Asia and currently employs around 13,400 people.

www.bormiolipharma.com

 

About Gerresheimer
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability. With over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets.  The Group generated revenues of around €2bn in 2023 and currently employs around 13,400 people. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).   www.gerresheimer.com

Contact Gerresheimer AG

Media  
Jutta Lorberg
Head of Corporate Communication
T +49 211 6181 264
jutta.lorberg@gerresheimer.com
Marion Stolzenwald
Senior Manager Corporate Communication
T +49 172 2424185
marion.stolzenwald@gerresheimer.com

Investor Relations
 
Guido Pickert
Vice President Investor Relations
T +49 152 900 14145
gerresheimer.ir@gerresheimer.com
 
Thomas Rosenke
Senior Manager Investor Relations
T: +49 211 6181-187
gerresheimer.ir@gerresheimer.com


11.12.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Gerresheimer AG
Klaus-Bungert-Str. 4
40468 Duesseldorf
Germany
Phone: +49-(0)211/61 81-00
Fax: +49-(0)211/61 81-121
E-mail: gerresheimer.ir@gerresheimer.com
Internet: http://www.gerresheimer.com
ISIN: DE000A0LD6E6
WKN: A0LD6E
Indices: MDAX (Aktie)
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2048177

 
End of News EQS News Service

2048177  11.12.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2048177&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2018 2019 2020 2021 2022 2023 2024e
Sales1 1.367,73 1.392,26 1.418,79 1.498,01 1.817,09 1.990,49 2.060,00
EBITDA1,2 298,60 400,01 310,14 306,31 340,87 399,42 422,00
EBITDA-Margin3 21,83 28,73 21,86 20,45 18,76 20,07 20,49
EBIT1,4 139,46 123,76 156,46 147,44 169,31 213,39 222,00
EBIT-Margin5 10,20 8,89 11,03 9,84 9,32 10,72 10,78
Net Profit (Loss)1 131,13 82,68 89,88 87,24 102,19 120,09 124,00
Net-Margin6 9,59 5,94 6,34 5,82 5,62 6,03 6,02
Cashflow1,7 173,47 192,92 222,19 212,08 221,94 294,34 0,00
Earnings per share8 4,11 2,57 2,82 2,67 3,06 3,48 2,56
Dividend per share8 1,15 1,20 1,25 1,25 1,25 1,25 1,40
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: Deloitte

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Gerresheimer
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
A0LD6E DE000A0LD6E6 AG 2.336,63 Mio € 11.06.2007 Halten 9F387QF9+73
* * *
PE 2025e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
16,91 23,92 0,71 20,54 1,67 7,94 1,17
Dividends
Dividend '2022
in €
Dividend '2023
in €
Dividend '2024e
in €
Div.-Yield '2024e
in %
1,25 1,25 1,40 2,07%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
05.06.2025 11.04.2025 10.07.2025 10.10.2024 26.02.2025
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
-7,27%
67,65 €
ATH 122,90 €
-12,73% -27,82% -28,30% -28,94% +69,13%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2024          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL